BOVESPA
124.543,19 -1.106,84 (-0,88%) MERVAL
38.390,84 +233,89 (+0,61%) MXX
56.096,46 -335,57 (-0,59%) PETROLEO CRU
76,59 -0,98 (-1,26%) OURO
2.335,80 -57,10 (-2,39%) Bitcoin USD
67.038,77 -2.401,79 (-3,46%)
A luta contra a COVID19
23,82k seguidores • 14 símbolos Lista de TREA
Siga esta lista para descobrir e acompanhar as ações de empresas de capital aberto com planos de saúde e tratamento relacionados à COVID-19.
Com curadoria de TREA
Desempenho
| Lista | Variação de hoje | Retorno de 1 mês | Retorno de 1 ano | Retorno total |
|---|---|---|---|---|
| A luta contra a COVID19 | -1.50% | - | - | - |
| ^GSPC | -0.82% | +3.78% | +27.90% | +5559.48% |
14 Símbolos
| Símbolo | Nome da empresa | Último Preço | Alterar | % de variação | Horário do Mercado | Volume | Volume médio (3 meses) | Capitalização de mercado |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 149.78 | -3.72 | -2.42% | 14:33 GMT-4 | 3,64M | 7,38M | 360,47B |
| ABBV | AbbVie Inc. | 159.1 | -0.51 | -0.32% | 14:33 GMT-4 | 2,46M | 5,63M | 280,95B |
| PFE | Pfizer Inc. | 28.765 | -0.84 | -2.82% | 14:33 GMT-4 | 28,11M | 42,69M | 163,00B |
| SNY | Sanofi | 49.005 | -1.35 | -2.69% | 14:33 GMT-4 | 1,89M | 1,97M | 122,48B |
| REGN | Regeneron Pharmaceuticals, Inc. | 985.0699 | +1.27 | +0.13% | 14:29 GMT-4 | 163,94k | 449,62k | 108,54B |
| GSK | GSK plc | 45.07 | -0.71 | -1.55% | 14:33 GMT-4 | 3,88M | 3,17M | 91,90B |
| GILD | Gilead Sciences, Inc. | 66.14 | -1.66 | -2.45% | 14:33 GMT-4 | 2,73M | 6,91M | 82,40B |
| MRNA | Moderna, Inc. | 162.495 | -0.84 | -0.51% | 14:33 GMT-4 | 5,04M | 3,86M | 62,27B |
| TAK | Takeda Pharmaceutical Company Limited | 13.015 | -0.05 | -0.34% | 14:32 GMT-4 | 780,40k | 1,56M | 41,04B |
| BNTX | BioNTech SE | 99.91 | -2.39 | -2.34% | 14:32 GMT-4 | 1,07M | 646,78k | 24,08B |
| NVAX | Novavax, Inc. | 15.085 | -0.61 | -3.92% | 14:33 GMT-4 | 13,41M | 12,87M | 2,22B |
| VIR | Vir Biotechnology, Inc. | 10.76 | -0.61 | -5.36% | 14:33 GMT-4 | 356,17k | 953,17k | 1,46B |
| INO | Inovio Pharmaceuticals, Inc. | 11.05 | -0.20 | -1.78% | 14:32 GMT-4 | 172,21k | 443,35k | 286,31M |
The Wall Street JournalHeard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
Moderna, BioNTech, CureVac and Novavax have added billions of dollars in combined market capitalization gains in recent days after two cases of bird flu were reported in humans in the U.S. and reports emerged of a potential federal government vaccine program. On Wednesday, Moderna gained 14% while BioNTech added 11%. CureVac jumped 19%.
ZacksPfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.
ZacksVaccine Stocks Rise on Growing Threat of Bird Flu Infections
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.
